A recent immunoblotting study [27] revealed that the amount of GAD 65 specific for axonal endings was unchanged in DLPFC in both medicated and medication-free MDD patients, which is consistent with our interpretation of the present findings (Table 3). This evidence concerns the gene GAD2 and major depressive disorder.